Precision Diagnostics Market 2023 : Industry Analysis, Growth, Drivers And Forecast 2032 | Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Abbott Laboratories

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Precision Diagnostics Global Market Report 2023 identifies rising prevalence of chronic diseases as the major driver for the Precision Diagnostics market's growth in the forecast period. Precision diagnostics help patients suffering from chronic diseases such as cancer and cardiovascular diseases by precisely managing a patient's healthcare model and diagnosing the disease with accurate results.

The global precision diagnostics market size is expected to grow from $75.28 billion in 2022 to $85.73 billion in 2023 at a compound annual growth rate (CAGR) of 13.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of precision diagnostics market is expected to reach $142.53 billion in 2027 at a CAGR of 13.6%.

Download Free Sample Of Precision Diagnostics Market Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=12025&type=smp

Major competitors in the Precision Diagnostics market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Abbott Laboratories, Danaher Corporation, Amgen Inc., Koninklijke Philips N.V., Becton Dickinson and Company (BD), Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Siemens Healthineers AG, Agilent Technologies Inc., PerkinElmer Inc., Beckman Coulter Inc., Charles River Laboratories International Inc., Sysmex America Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Bio-Techne Corporation, Illumina Inc., Lantheus Medical Imaging Inc., Luminex Corporation, BioFire Diagnostics LLC, Genomic Health Inc., Swiss Precision Diagnostics GmbH, and Bluebird Bio Inc.

A key trend in the Precision Diagnostics market includes introduction of innovative therapy. Major companies operating in the precision diagnostics market are adopting new technologies to sustain their position in the market. For instance, in July 2021, Xyall BV, a Netherlands-based automated tissue dissection solution company, launched Automated High Throughput (HT) system for greater precision diagnostics.

Read More On The Global Precision Diagnostics Market Report Here:
https://www.thebusinessresearchcompany.com/report/precision-diagnostics-global-market-report

The Precision Diagnostics market is segmented -

By Type: Genetic Tests, Esoteric tests, Other Types

By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Mass Spectrometry, Immunohistochemistry (IHC), Other Technologies

By Application: Oncology, Infectious diseases, Cardiovascular, Neurology, Genetic disorders, Other Applications

By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical and biotechnology Companies, Other End-Users

By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Precision Diagnostics market.

The Business Research Company's "Global Precision Diagnostics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Precision Diagnostics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12025

The Table Of Content For The Precision Diagnostics Market Include:
1. Executive Summary
2. Precision Diagnostics Market Characteristics
3. Precision Diagnostics Market Trends And Strategies
4. Precision Diagnostics Market - Macro Economic Scenario
5. Global Precision Diagnostics Historic Market Size and Growth, 2017 - 2022, Value ($ Billion
……
32. Global Precision Diagnostics Market Competitive Benchmarking
33. Global Precision Diagnostics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Precision Diagnostics Market
35. Precision Diagnostics Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.